Centre Imposes Quantitative Restriction On Export Of Syringes To Boost Domestic Production, Supply

Restriction applies to just 3 categories of syringes for 3 months

vaccine

The Domestic Vaccine Manufacturers and Manufacturers of Syringes have played an important and critical role in the effective implementation of World’s largest COVID Vaccination Program in India. India has so far administered nearly 94 Crore Vaccine doses and is nearing 100 Crore doses administration mark. With a firm political commitment to vaccinate India’s last citizen, fulfilling the philosophy of ‘Antyodaya’ espoused by Pt. Deendayal Upadhyay, the Government has put in place a quantitative restriction on the export of syringes to boost their domestic availability and uptake.

Syringes are vital to sustain the momentum of the program to vaccinate all eligible Citizens in shortest possible time. With a view to ensure adequate availability of the syringes, used to administer the vaccine, the Government of India has enacted this quantitative restriction on the export of the following denominations of the syringes only: –

  • 0.5 ml/ 1ml AD (auto-disable) syringes.
  • 0.5 ml/1 ml/2 ml/3 ml disposable syringes.
  • 1ml/2 ml/3 ml RUP (re-use prevention) syringes.

It is also clarified that it is not an Export ban on any kind/Type of Syringes, it is only quantitative restriction on the export of certain type of specified syringes, for a limited duration of 3 months. Further, the syringes of denominations and types other than those mentioned above are not covered under Quantitative Restriction.

With the administration of 79,12,202vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage nearly reaches 94Cr(93,99,15,323) as per provisional reports till 7 am today.  This has been achieved through 91,40,316sessions.

The recovery of23,070patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,32,48,291.

Consequently, India’s recovery rate stands at 97.98%. The recovery rate is currently at its highest peak since March 2020.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 104 consecutive days now.

19,740new cases were reported in the last 24 hours.

The Active Caseload is presently2,36,643, which is the lowest in 206days. Active cases presently constitute 0.70% of the country’s total Positive Cases.

Facebook Comments